Browsing by keyword "Self-Efficacy"
Now showing items 1-2 of 2
-
Depression predicts chronic pain interference in racially diverse, income-disadvantaged patientsBACKGROUND: Chronic pain is one of the most common reasons adults seek medical care in the US, with prevalence estimates ranging from 11% to 40%. Mindfulness meditation has been associated with significant improvements in pain, depression, physical and mental health, sleep, and overall quality of life. Group medical visits are increasingly common and are effective at treating myriad illnesses, including chronic pain. Integrative Medical Group Visits (IMGV) combine mindfulness techniques, evidence based integrative medicine, and medical group visits and can be used as adjuncts to medications, particularly in diverse underserved populations with limited access to non-pharmacological therapies. OBJECTIVE AND DESIGN: The objective of the present study was to use a blended analytical approach of machine learning and regression analyses to evaluate the potential relationship between depression and chronic pain in data from a randomized clinical trial of IMGV in diverse, income disadvantaged patients suffering from chronic pain and depression. METHODS: The analytical approach used machine learning to assess the predictive relationship between depression and pain and identify and select key mediators, which were then assessed with regression analyses. It was hypothesized that depression would predict the pain outcomes of average pain, pain severity, and pain interference. RESULTS: Our analyses identified and characterized a predictive relationship between depression and chronic pain interference. This prediction was mediated by high perceived stress, low pain self-efficacy, and poor sleep quality, potential targets for attenuating the adverse effects of depression on functional outcomes. CONCLUSIONS: In the context of the associated clinical trial and similar interventions, these insights may inform future treatment optimization, targeting, and application efforts in racialized, income disadvantaged populations, demographics often neglected in studies of chronic pain. TRIAL REGISTRATION: NCT from clinicaltrials.gov: 02262377. American Academy of Pain Medicine.
-
Development and validation of the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD)OBJECTIVES: To develop and validate a self-efficacy measure of diabetes self-management, the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD), designed for low-income, Spanish-speaking Latinos with diabetes. DESIGN: Quantitative and qualitative methods. SETTING: Community health centers in central and western Massachusetts. PARTICIPANTS: Low-income Latinos (N = 252) enrolled in a randomized diabetes self-management intervention trial. MEASURES: Construct validity, internal consistency, sensitivity to change over time. RESULTS: The LSESLD demonstrated good internal consistency (Cronbach's alpha = .85), reasonable construct validity (moderate, significant associations between the LSESLD and validated measures of diabetes knowledge, dietary intake, physical activity, blood glucose self-monitoring, and HbA1c values), and sensitivity to intervention-related changes over time. CONCLUSION: The LSESLD is a reliable and valid research instrument assessing self-efficacy related to diabetes self-management among low-income, Spanish-speaking populations.